Chemicals & Advanced Materials Global On demand · 24-48h

Global 1-Adamantanol Market Strategic Research Report

Global 1-Adamantanol Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global 1-Adamantanol Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Purity≥99%, Purity≥98%, Other

By Application: Pharmaceuticals, Organic Synthesis, Other

Key Players: Tianjin Minxiang Biomedical, Sichuan Zhongbang New Material, Haicheng Liqi Carbon Material, Jinxiang Chemical Enterprise, Yibin chemist Pharmachem, Freesia Chemicals

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 95 pages

Overzicht

Scope of the Report

1-Adamantanol is a white crystalline powder, an organic compound belonging to the adamantane-derived tertiary alcohols. It is insoluble in water but soluble in organic solvents and sublimes easily. This substance is an important basic raw material for the synthesis of high-value adamantane derivatives, pharmaceutical intermediates (such as adapalene), and special materials.

The main raw material for the production of 1-adamantanol is adamantane. 1-Adamantanol can be directly produced by oxidizing adamantane with an oxidizing agent (such as nitric acid, potassium permanganate, or other oxidation systems). This process usually requires a solvent and is mainly used in the production of pharmaceutical intermediates such as adapalene and 1-adamantaneacetic acid.

In 2025, global sales are projected to be approximately 5,000 tons, with an average market price of around $2,210 per ton. The industry's gross profit margin is expected to be in the range of 15%–25%.

The demand for high-end pharmaceutical intermediates is the main driving force behind the 1-adamantanol industry. 1-adamantanol is a key precursor in the synthesis of various adamantane-based drugs, which are irreplaceable in the treatment of central nervous system diseases such as antiviral infections, Alzheimer's disease, and Parkinson's disease due to the high penetration ability conferred by the adamantane skeleton. With the development of an aging society, the market for these drugs is steadily increasing. Furthermore, the evolution of synthesis processes towards greener and more efficient methods (such as biocatalysis) is also an important driving force for technological progress. At the same time, the industry faces various pressures, including environmental concerns.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 1-Adamantanol market?

What factors are driving 1-Adamantanol market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 1-Adamantanol market opportunities vary by end market size?

How does 1-Adamantanol break out by Type, by Application?

This report presents a comprehensive overview of the global 1-Adamantanol market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Purity≥99%
  • Purity≥98%
  • Other

Segment by Grade

  • Pharmaceutical Grade
  • Industrial Grade

Segment by Process

  • Direct Oxidation Method
  • Chlorination and Hydrolysis Method
  • Other

Segment by Application

  • Pharmaceuticals
  • Organic Synthesis
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 1-Adamantanol market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceuticals, Organic Synthesis, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Purity≥99%Purity≥98%Other
By Application
PharmaceuticalsOrganic SynthesisOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Purity≥99%
  • 3.1.3 Purity≥98%
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceuticals
  • 4.1.3 Organic Synthesis
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Tianjin Minxiang Biomedical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Sichuan Zhongbang New Material
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Haicheng Liqi Carbon Material
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Jinxiang Chemical Enterprise
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Yibin chemist Pharmachem
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Freesia Chemicals
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How is 1-Adamantanol defined?
1-Adamantanol is a white crystalline powder, an organic compound belonging to the adamantane-derived tertiary alcohols. It is insoluble in water but soluble in organic solvents and sublimes easily. This substance is an important basic raw material for the synthesis of high-value adamantane derivatives, pharmaceutical intermediates (such as adapalene), and special materials.
How is the 1-Adamantanol market segmented by type?
By type, the market is segmented into Purity≥99%, Purity≥98% and Other.
What are the key applications of 1-Adamantanol?
Key applications covered include Pharmaceuticals, Organic Synthesis and Other.
Which companies are profiled in the 1-Adamantanol market report?
Key players profiled include Tianjin Minxiang Biomedical, Sichuan Zhongbang New Material, Haicheng Liqi Carbon Material, Jinxiang Chemical Enterprise, Yibin chemist Pharmachem and Freesia Chemicals.
What geographies does the 1-Adamantanol market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for 1-Adamantanol?
Furthermore, the evolution of synthesis processes towards greener and more efficient methods (such as biocatalysis) is also an important driving force for technological progress.
Who should buy the 1-Adamantanol market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceuticals, Organic Synthesis and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the 1-Adamantanol market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.